HIV and cervical cancer in Kenya

Int J Gynaecol Obstet. 2002 Jan;76(1):55-63. doi: 10.1016/s0020-7292(01)00560-4.

Abstract

Objectives: To determine the effect of the HIV epidemic on invasive cervical cancer in Kenya.

Methods: Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital (KNH) from 1989 to 1998, 85% had invasive cervical cancer. Age at presentation and severity of cervical cancer were studied for a 9-year period when national HIV prevalence went from 5% to 5-10%, to 10-15%.

Results: There was no significant change in either age at presentation or severity of cervical cancer. Of the 118 (5%) women who were tested for HIV, 36 (31%) were seropositive. These women were 5 years younger at presentation than HIV-negative women.

Conclusions: A two- to three-fold increase in HIV prevalence in Kenya did not seem to have a proportional effect on the incidence of cervical cancer. Yet, HIV-positive women who presented with cervical cancer were significantly younger than HIV-negative women.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / epidemiology*
  • Adenocarcinoma / etiology*
  • Adenocarcinoma / pathology
  • Adult
  • Age Factors
  • Carcinoma, Squamous Cell / epidemiology*
  • Carcinoma, Squamous Cell / etiology*
  • Carcinoma, Squamous Cell / pathology
  • Female
  • HIV Infections / complications*
  • HIV Infections / epidemiology*
  • HIV Infections / pathology
  • Humans
  • Incidence
  • Kenya / epidemiology
  • Middle Aged
  • Neoplasm Staging
  • Prevalence
  • Retrospective Studies
  • Severity of Illness Index
  • Uterine Cervical Neoplasms / epidemiology*
  • Uterine Cervical Neoplasms / etiology*
  • Uterine Cervical Neoplasms / pathology